Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis
There is a significant research gap in meta-analysis on the efficacy and safety of coronavirus
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
COVID-19 vaccines: breaking record times to first-in-human trials
YC Kim, B Dema, A Reyes-Sandoval - npj Vaccines, 2020 - nature.com
COVID-19 vaccines: breaking record times to first-in-human trials | npj Vaccines Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
[HTML][HTML] A review on the advancements in the development of vaccines to combat coronavirus disease 2019
H Onyeaka, ZT Al-Sharify, MY Ghadhban… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV-
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
Review on up-to-date status of candidate vaccines for COVID-19 disease
TM Belete - Infection and drug resistance, 2021 - Taylor & Francis
The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread and poses
serious threats to public health and economic stability throughout the world. Thus, to protect …
serious threats to public health and economic stability throughout the world. Thus, to protect …
COVID-19 vaccines, effectiveness, and immune responses
HI Abufares, L Oyoun Alsoud, MAY Alqudah… - International journal of …, 2022 - mdpi.com
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …
COVID-19 and vaccination: myths vs science
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
N Asghar, H Mumtaz, AA Syed, F Eqbal… - Immunological …, 2022 - Taylor & Francis
Abstract The World Health Organization stated on 11 March 2020 that a coronavirus illness
had been discovered in Wuhan, China in December 2019. Effective vaccinations are …
had been discovered in Wuhan, China in December 2019. Effective vaccinations are …
COVID-19 vaccines: current and future perspectives
L Soraci, F Lattanzio, G Soraci, ME Gambuzza… - Vaccines, 2022 - mdpi.com
Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …